Amaducci, Alexandra

Beauchamp, Gillian A, MD

Careyva, Beth

Cook, Matthew D

Greenberg, Marna

Hardy, Olivia A

Katz, Kenneth

Koons, Andrew

Sabino, Judith

Surmaitis, Ryan

Zachary, Joseph B

English

Cook, Matthew D, DO

Surmaitis, Ryan, DO

Zackary, Joseph B, MD

Lehigh Valley Health Network: LVHN Scholarly Works

Lehigh Valley Health Network LVHN Scholarly Works Department of Family Medicine Agents of exposure in transgender patient cases managed by a toxicologist: An analysis of the toxicology investigators consortium (ToxIC) registry Olivia A. Hardy Alexandra Amaducci Judith Sabino Beth Careyva Matthew D Cook See next page for additional authors Follow this and additional works at: https://scholarlyworks.lvhn.org/family-medicine  Part of the Public Health Education and Promotion Commons This Poster is brought to you for free and open access by LVHN Scholarly Works. It has been accepted for inclusion in LVHN Scholarly Works by an authorized administrator. For more information, please contact LibraryServices@lvhn.org. Authors Olivia A. Hardy, Alexandra Amaducci, Judith Sabino, Beth Careyva, Matthew D Cook, Kenneth Katz, Marna Greenberg, Ryan Surmaitis, Andrew Koons, Joseph B. Zachary, and Gillian A. Beauchamp MD © 2021 Lehigh Valley Health NetworkLVHN.orgAgents of Exposure in Transgender Patient Cases Managed by a Toxicologist: An Analysis of the Toxicology Investigator’s Consortium (ToxIC) RegistryOlivia A. Hardy, BS, Alexandra M. Amaducci, DO, Judith N. Sabino, MPH, Beth A. Careyva, MD, Matthew D. Cook, DO, Kenneth D. Katz, MD, Marna Rayl-Greenberg, DO, MPH Ryan M. Surmaitis, DO, Andrew L. Koons, DO, Joseph B. Zachary, MD, Gillian A. Beauchamp, MDOn behalf of the Toxicology Investigators Consortium (ToxIC) Study GroupLehigh Valley Health Network/University of South Florida Morsani College of Medicine, Lehigh Valley Campus, Allentown, PAStudy ObjectiveLittle is known regarding trends in poisonings  within the transgender community. We set out  to review medical encounters managed by a medical toxicologist and provide descriptive data  in trends among types of exposures within the transgender demographic. MethodsThe Toxicology Investigators Consortium (ToxIC) database was created in 2010 by the American College of Medical Toxicology (ACMT) to compile data recorded by medical toxicologists. In January 2017 the data field for transgender (and, if transgender, male to female or female to male)  was added to the ToxIC form. Between January, 2017–December, 2020 a retrospective ToxIC database review of transgender cases including descriptive demographics was performed.ResultsThere were 195 transgender cases. Among these, 61.5% (N=120) were female-to-male, 32.8% (N=64) were male-to-female, and 5.6% (N=11) were gender nonconforming. In regards to race, 63.1% (N=123) were Caucasian, 6.2% (N=12) Black/African American, 3.6% (N=7) Asian, 2% (N=4) mixed race, 1% (N=2) American Indian/Alaskan Native, 0.5% (N=1) Native Hawaiian or Pacific Islander, and 23.6% (N=46) unknown. In regards to ethnicity, 7.2% (N=14) of cases were Latino/Hispanic, 62.6% (N=122) not Latino/Hispanic, and 30.2% (N=59) unknown. Of the 195 transgender cases, 49.7% (N=97) were 13-18 years old, 46.2% (N=90) 19-65 years old, 3.1% (N=6) 7-12 years old, and 1% (N=2) 66-89 years old. In this cohort there were no reported deaths.Overall, 88.2% (N=172) of the poisonings involved pharmaceutical drugs – 98.3% (N=169) of which were intentional ingestions. Twenty-one percent (N=41) were analgesics, 20% (N=39) antidepressants, 8.7% (N=17) anti-cholinergic/anti-histamines, 7.2% (N=14) antipsychotics, 7.2% (N=14) anticonvulsants/mood stabilizers, 4.6% (N=9) cardiovascular medications, 4.1% (N=8) opioids, 3.6% (N=7) ethanol; 2.6% (N=5) sympathomimetics, 2.6% (N=5) household substances, 2% (N=4) cough & cold medications, 2% (N=4) sedative/hypnotic/muscle relaxants, 1.5% (N=3) other pharmaceuticals, 1% (N=2) psychoactive substances, 1% (N=2) diabetic medications, 1% (N=2) caustic ingestions, 1% (N=2) toxic alcohols (specifically ethylene glycol and isopropanol); 0.5% (N=1) metals, 0.5% (N=1) herbals/dietary supplements/vitamins, 0.5% (N=1) GI medications, 0.5% (N=1) envenomations; 0.5% (N=1) chemotherapeutic/immune medications, 0.5% (N=1) antimicrobials, 0.5% (N=1) anticoagulants, and 5.1% (N=10) unknown or not reported.ConclusionAmong transgender patients with poisonings reported to the ToxIC registry, the majority were adolescent Caucasians who ingested either analgesic or psychotropic medications. These data may be helpful to develop poisoning prevention practices in this vulnerable population. 195 transgender cases 61.5% female-to-male  32.8% male-to-female  5.6% gender nonconformingThis study was funded, in part, by the Dorothy Rider Pool Health Care Trust Research and Development Award for Clinical Excellence.

Agents of exposure in transgender patient cases managed by a toxicologist: An analysis of the toxicology investigators consortium (ToxIC) registry

https://scholarlyworks.lvhn.org/cgi/viewcontent.cgi?article=1746&context=family-medicine

Agents of exposure in transgender patient cases managed by a toxicologist: An analysis of the toxicology investigators consortium (ToxIC) registry

Abstract

Similar works

Full text

Available Versions

Lehigh Valley Health Network: LVHN Scholarly Works